Skip to main content
Erschienen in: Breast Cancer Research and Treatment 2/2018

05.06.2018 | Epidemiology

The relationship between patient and tumor characteristics, patterns of breast cancer care, and 5-year survival among elderly women with incident breast cancer

verfasst von: Amanda L. Kong, Ann B. Nattinger, Emily McGinley, Liliana E. Pezzin

Erschienen in: Breast Cancer Research and Treatment | Ausgabe 2/2018

Einloggen, um Zugang zu erhalten

Abstract

Purpose

To examine the relationship between patient and tumor characteristics, patterns of breast cancer care, and 5-year survival among a population-based cohort of elderly women with incident breast cancer, with a special focus on identifying sources of socioeconomic (SES) disparities in outcomes.

Methods

We identified women with newly diagnosed breast cancer in 2006–2009 from the Surveillance and Epidemiology End Result study linked with Medicare claims. A Classification and Regression Tree (CART) model was applied to 13 individual indicators of neoadjuvant and adjuvant breast cancer treatment, tumor characteristics, and patient sociodemographic variables to identify patterns with the greatest discriminant value in predicting 5-year survival. We subsequently examined the extent to which these patterns varied by the patient’s SES.

Results

Survival probabilities associated with the 18 unique CART-identified patterns ranged from 22 to 87%. The number of positive axillary nodes was the best single discriminator between high and lower survival outcomes. The most common discriminant factor among patterns with poor (< 25%) survival was the absence of radiation treatment, followed by the presence of comorbidities, tumor size > 2 cm, and no breast surgery. Relative to high SES women, poor women were nearly four times (12.3% vs. 3.2%, p < 0.001) as likely to be classified in the pattern associated with worse survival, and less likely (31.7% vs. 52.9%, p = 0.04) to receive the pattern associated with the greatest survival.

Conclusions

Greater adoption of effective patterns of care could improve survival of elderly women with incident breast cancer overall, and reduce SES disparities therein.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Singh GK, Miller B, Hankey B, Edwards BK (2003) Area socioeconomic variations in U.S. Cancer Incidence, Mortality, Stage, Treatment, and Survival, 1975–1999. In. National Cancer Institute, Bethesda Singh GK, Miller B, Hankey B, Edwards BK (2003) Area socioeconomic variations in U.S. Cancer Incidence, Mortality, Stage, Treatment, and Survival, 1975–1999. In. National Cancer Institute, Bethesda
2.
Zurück zum Zitat Gordon NH, Crowe JP, Brumberg DJ, Berger NA (1992) Socioeconomic factors and race in breast cancer recurrence and survival. Am J Epidemiol 135(6):609–618CrossRefPubMed Gordon NH, Crowe JP, Brumberg DJ, Berger NA (1992) Socioeconomic factors and race in breast cancer recurrence and survival. Am J Epidemiol 135(6):609–618CrossRefPubMed
3.
Zurück zum Zitat Gorey KM, Luginaah IN, Holowaty EJ, Fung KY, Hamm C (2009) Breast cancer survival in Ontario and California, 1998–2006: socioeconomic inequity remains much greater in the United States. Ann Epidemiol 19(2):121–124CrossRefPubMedPubMedCentral Gorey KM, Luginaah IN, Holowaty EJ, Fung KY, Hamm C (2009) Breast cancer survival in Ontario and California, 1998–2006: socioeconomic inequity remains much greater in the United States. Ann Epidemiol 19(2):121–124CrossRefPubMedPubMedCentral
4.
Zurück zum Zitat Sprague BL, Trentham-Dietz A, Gangnon RE, Ramchandani R, Hampton JM, Robert SA, Remington PL, Newcomb PA (2011) Socioeconomic status and survival after an invasive breast cancer diagnosis. Cancer 117(7):1542–1551CrossRefPubMed Sprague BL, Trentham-Dietz A, Gangnon RE, Ramchandani R, Hampton JM, Robert SA, Remington PL, Newcomb PA (2011) Socioeconomic status and survival after an invasive breast cancer diagnosis. Cancer 117(7):1542–1551CrossRefPubMed
5.
Zurück zum Zitat Harper S, Lynch J, Meersman SC, Breen N, Davis WW, Reichman MC (2009) Trends in area-socioeconomic and race-ethnic disparities in breast cancer incidence, stage at diagnosis, screening, mortality, and survival among women ages 50 years and over (1987–2005). Cancer Epidemiol Biomark Prev 18(1):121–131CrossRef Harper S, Lynch J, Meersman SC, Breen N, Davis WW, Reichman MC (2009) Trends in area-socioeconomic and race-ethnic disparities in breast cancer incidence, stage at diagnosis, screening, mortality, and survival among women ages 50 years and over (1987–2005). Cancer Epidemiol Biomark Prev 18(1):121–131CrossRef
6.
Zurück zum Zitat Byers TE, Wolf HJ, Bauer KR, Bolick-Aldrich S, Chen VW, Finch JL, Fulton JP, Schymura MJ, Shen T, Van Heest S et al (2008) The impact of socioeconomic status on survival after cancer in the United States: findings from the National Program of Cancer Registries Patterns of Care Study. Cancer 113(3):582–591CrossRefPubMed Byers TE, Wolf HJ, Bauer KR, Bolick-Aldrich S, Chen VW, Finch JL, Fulton JP, Schymura MJ, Shen T, Van Heest S et al (2008) The impact of socioeconomic status on survival after cancer in the United States: findings from the National Program of Cancer Registries Patterns of Care Study. Cancer 113(3):582–591CrossRefPubMed
8.
Zurück zum Zitat Kish JK, Yu M, Percy-Laurry A, Altekruse SF (2014) Racial and ethnic disparities in cancer survival by neighborhood socioeconomic status in Surveillance, Epidemiology, and End Results (SEER) Registries. J Natl Cancer Inst Monogr 2014(49):236–243CrossRefPubMedPubMedCentral Kish JK, Yu M, Percy-Laurry A, Altekruse SF (2014) Racial and ethnic disparities in cancer survival by neighborhood socioeconomic status in Surveillance, Epidemiology, and End Results (SEER) Registries. J Natl Cancer Inst Monogr 2014(49):236–243CrossRefPubMedPubMedCentral
9.
Zurück zum Zitat Feinglass J, Rydzewski N, Yang A (2015) The socioeconomic gradient in all-cause mortality for women with breast cancer: findings from the 1998 to 2006 National Cancer Data Base with follow-up through 2011. Ann Epidemiol 25(8):549–555CrossRefPubMed Feinglass J, Rydzewski N, Yang A (2015) The socioeconomic gradient in all-cause mortality for women with breast cancer: findings from the 1998 to 2006 National Cancer Data Base with follow-up through 2011. Ann Epidemiol 25(8):549–555CrossRefPubMed
10.
Zurück zum Zitat Gilligan MA, Kneusel RT, Hoffmann RG, Greer AL, Nattinger AB (2002) Persistent differences in sociodemographic determinants of breast conserving treatment despite overall increased adoption. Med Care 40(3):181–189CrossRefPubMed Gilligan MA, Kneusel RT, Hoffmann RG, Greer AL, Nattinger AB (2002) Persistent differences in sociodemographic determinants of breast conserving treatment despite overall increased adoption. Med Care 40(3):181–189CrossRefPubMed
11.
Zurück zum Zitat Nattinger AB, Wozniak EM, McGinley EL, Li J, Laud P, Pezzin LE (2017) Socioeconomic disparities in mortality among women with incident breast cancer before and after implementation of medicare Part D. Med Care 55(5):463–469CrossRefPubMed Nattinger AB, Wozniak EM, McGinley EL, Li J, Laud P, Pezzin LE (2017) Socioeconomic disparities in mortality among women with incident breast cancer before and after implementation of medicare Part D. Med Care 55(5):463–469CrossRefPubMed
13.
Zurück zum Zitat Reeder-Hayes K, Peacock Hinton S, Meng K, Carey LA, Dusetzina SB (2016) Disparities in use of human epidermal growth hormone receptor 2-targeted therapy for early-stage breast cancer. J Clin Oncol 34(17):2003–2009CrossRefPubMedPubMedCentral Reeder-Hayes K, Peacock Hinton S, Meng K, Carey LA, Dusetzina SB (2016) Disparities in use of human epidermal growth hormone receptor 2-targeted therapy for early-stage breast cancer. J Clin Oncol 34(17):2003–2009CrossRefPubMedPubMedCentral
14.
Zurück zum Zitat Lautner M, Lin H, Shen Y, Parker C, Kuerer H, Shaitelman S, Babiera G, Bedrosian I (2015) Disparities in the use of breast-conserving therapy among patients with early-stage breast cancer. JAMA Surg 150(8):778–786CrossRefPubMedPubMedCentral Lautner M, Lin H, Shen Y, Parker C, Kuerer H, Shaitelman S, Babiera G, Bedrosian I (2015) Disparities in the use of breast-conserving therapy among patients with early-stage breast cancer. JAMA Surg 150(8):778–786CrossRefPubMedPubMedCentral
15.
Zurück zum Zitat Royak-Schaler R, Pelser C, Langenberg P, Hayes J, Gardner L, Nesbitt K, Citron W, Drogula CL, Dwyer D (2012) Characteristics associated with the initiation of radiation therapy after breast-conserving surgery among African American and white women diagnosed with early-stage breast cancer in Maryland, 2000–2006. Ann Epidemiol 22(1):28–36CrossRefPubMed Royak-Schaler R, Pelser C, Langenberg P, Hayes J, Gardner L, Nesbitt K, Citron W, Drogula CL, Dwyer D (2012) Characteristics associated with the initiation of radiation therapy after breast-conserving surgery among African American and white women diagnosed with early-stage breast cancer in Maryland, 2000–2006. Ann Epidemiol 22(1):28–36CrossRefPubMed
16.
Zurück zum Zitat Parise CA, Bauer KR, Caggiano V (2012) Disparities in receipt of adjuvant radiation therapy after breast-conserving surgery among the cancer-reporting regions of California. Cancer 118(9):2516–2524CrossRefPubMed Parise CA, Bauer KR, Caggiano V (2012) Disparities in receipt of adjuvant radiation therapy after breast-conserving surgery among the cancer-reporting regions of California. Cancer 118(9):2516–2524CrossRefPubMed
17.
Zurück zum Zitat Chen AY, Halpern MT, Schrag NM, Stewart A, Leitch M, Ward E (2008) Disparities and trends in sentinel lymph node biopsy among early-stage breast cancer patients (1998–2005). J Natl Cancer Inst 100(7):462–474CrossRefPubMed Chen AY, Halpern MT, Schrag NM, Stewart A, Leitch M, Ward E (2008) Disparities and trends in sentinel lymph node biopsy among early-stage breast cancer patients (1998–2005). J Natl Cancer Inst 100(7):462–474CrossRefPubMed
18.
Zurück zum Zitat Reeder-Hayes KE, Bainbridge J, Meyer AM, Amos KD, Weiner BJ, Godley PA, Carpenter WR (2011) Race and age disparities in receipt of sentinel lymph node biopsy for early-stage breast cancer. Breast Cancer Res Treat 128(3):863–871CrossRefPubMedPubMedCentral Reeder-Hayes KE, Bainbridge J, Meyer AM, Amos KD, Weiner BJ, Godley PA, Carpenter WR (2011) Race and age disparities in receipt of sentinel lymph node biopsy for early-stage breast cancer. Breast Cancer Res Treat 128(3):863–871CrossRefPubMedPubMedCentral
20.
Zurück zum Zitat Breiman L, Friedman JH, Olshen RA, Stone CJ (1984) Classification and regression trees. Wadsworth & Brooks/Cole Advanced Books & Software, Monterey Breiman L, Friedman JH, Olshen RA, Stone CJ (1984) Classification and regression trees. Wadsworth & Brooks/Cole Advanced Books & Software, Monterey
21.
Zurück zum Zitat Klabunde CN, Potosky AL, Legler JM, Warren JL (2000) Development of a comorbidity index using physician claims data. J Clin Epidemiol 53(12):1258–1267CrossRefPubMed Klabunde CN, Potosky AL, Legler JM, Warren JL (2000) Development of a comorbidity index using physician claims data. J Clin Epidemiol 53(12):1258–1267CrossRefPubMed
22.
Zurück zum Zitat Chavez-MacGregor M, Clarke CA, Lichtensztajn DY, Giordano SH (2016) Delayed initiation of adjuvant chemotherapy among patients with breast cancer. JAMA Oncol 2(3):322–329CrossRefPubMedPubMedCentral Chavez-MacGregor M, Clarke CA, Lichtensztajn DY, Giordano SH (2016) Delayed initiation of adjuvant chemotherapy among patients with breast cancer. JAMA Oncol 2(3):322–329CrossRefPubMedPubMedCentral
23.
Zurück zum Zitat Hershman DL, Wang X, McBride R, Jacobson JS, Grann VR, Neugut AI (2006) Delay in initiating adjuvant radiotherapy following breast conservation surgery and its impact on survival. Int J Radiat Oncol Biol Phys 65(5):1353–1360CrossRefPubMed Hershman DL, Wang X, McBride R, Jacobson JS, Grann VR, Neugut AI (2006) Delay in initiating adjuvant radiotherapy following breast conservation surgery and its impact on survival. Int J Radiat Oncol Biol Phys 65(5):1353–1360CrossRefPubMed
24.
Zurück zum Zitat Hershman DL, Wang X, McBride R, Jacobson JS, Grann VR, Neugut AI (2006) Delay of adjuvant chemotherapy initiation following breast cancer surgery among elderly women. Breast Cancer Res Treat 99(3):313–321CrossRefPubMed Hershman DL, Wang X, McBride R, Jacobson JS, Grann VR, Neugut AI (2006) Delay of adjuvant chemotherapy initiation following breast cancer surgery among elderly women. Breast Cancer Res Treat 99(3):313–321CrossRefPubMed
25.
Zurück zum Zitat Saadatmand S, Bretveld R, Siesling S, Tilanus-Linthorst MM (2015) Influence of tumour stage at breast cancer detection on survival in modern times: population based study in 173,797 patients. BMJ 351:h4901CrossRefPubMedPubMedCentral Saadatmand S, Bretveld R, Siesling S, Tilanus-Linthorst MM (2015) Influence of tumour stage at breast cancer detection on survival in modern times: population based study in 173,797 patients. BMJ 351:h4901CrossRefPubMedPubMedCentral
26.
Zurück zum Zitat Michaelson JS, Silverstein M, Sgroi D, Cheongsiatmoy JA, Taghian A, Powell S, Hughes K, Comegno A, Tanabe KK, Smith B (2003) The effect of tumor size and lymph node status on breast carcinoma lethality. Cancer 98(10):2133–2143CrossRefPubMed Michaelson JS, Silverstein M, Sgroi D, Cheongsiatmoy JA, Taghian A, Powell S, Hughes K, Comegno A, Tanabe KK, Smith B (2003) The effect of tumor size and lymph node status on breast carcinoma lethality. Cancer 98(10):2133–2143CrossRefPubMed
27.
Zurück zum Zitat Say CC, Donegan WL (1974) Invasive carcinoma of the breast: prognostic significance of tumor size and involved axillary lymph nodes. Cancer 34(2):468–471CrossRefPubMed Say CC, Donegan WL (1974) Invasive carcinoma of the breast: prognostic significance of tumor size and involved axillary lymph nodes. Cancer 34(2):468–471CrossRefPubMed
28.
Zurück zum Zitat Braithwaite D, Moore DH, Satariano WA, Kwan ML, Hiatt RA, Kroenke C, Caan BJ (2012) Prognostic impact of comorbidity among long-term breast cancer survivors: results from the LACE study. Cancer Epidemiol Biomarkers Prev 21(7):1115–1125CrossRefPubMedPubMedCentral Braithwaite D, Moore DH, Satariano WA, Kwan ML, Hiatt RA, Kroenke C, Caan BJ (2012) Prognostic impact of comorbidity among long-term breast cancer survivors: results from the LACE study. Cancer Epidemiol Biomarkers Prev 21(7):1115–1125CrossRefPubMedPubMedCentral
29.
Zurück zum Zitat Zhao XB, Ren GS (2016) Diabetes mellitus and prognosis in women with breast cancer: A systematic review and meta-analysis. Medicine (Baltimore) 95(49):e5602CrossRef Zhao XB, Ren GS (2016) Diabetes mellitus and prognosis in women with breast cancer: A systematic review and meta-analysis. Medicine (Baltimore) 95(49):e5602CrossRef
30.
Zurück zum Zitat Chen L, Linden HM, Anderson BO, Li CI (2014) Trends in 5-year survival rates among breast cancer patients by hormone receptor status and stage. Breast Cancer Res Treat 147(3):609–616CrossRefPubMedPubMedCentral Chen L, Linden HM, Anderson BO, Li CI (2014) Trends in 5-year survival rates among breast cancer patients by hormone receptor status and stage. Breast Cancer Res Treat 147(3):609–616CrossRefPubMedPubMedCentral
31.
Zurück zum Zitat Early Breast Cancer Trialists’ Collaborative G, Peto R, Davies C, Godwin J, Gray R, Pan HC, Clarke M, Cutter D, Darby S, McGale P et al (2012) Comparisons between different polychemotherapy regimens for early breast cancer: meta-analyses of long-term outcome among 100,000 women in 123 randomised trials. Lancet 379(9814):432–444CrossRef Early Breast Cancer Trialists’ Collaborative G, Peto R, Davies C, Godwin J, Gray R, Pan HC, Clarke M, Cutter D, Darby S, McGale P et al (2012) Comparisons between different polychemotherapy regimens for early breast cancer: meta-analyses of long-term outcome among 100,000 women in 123 randomised trials. Lancet 379(9814):432–444CrossRef
32.
Zurück zum Zitat Early Breast Cancer Trialists’ Collaborative G (2015) Aromatase inhibitors versus tamoxifen in early breast cancer: patient-level meta-analysis of the randomised trials. Lancet 386(10001):1341–1352CrossRef Early Breast Cancer Trialists’ Collaborative G (2015) Aromatase inhibitors versus tamoxifen in early breast cancer: patient-level meta-analysis of the randomised trials. Lancet 386(10001):1341–1352CrossRef
33.
Zurück zum Zitat Early Breast Cancer Trialists’ Collaborative G, Davies C, Godwin J, Gray R, Clarke M, Cutter D, Darby S, McGale P, Pan HC, Taylor C (2011) Relevance of breast cancer hormone receptors and other factors to the efficacy of adjuvant tamoxifen: patient-level meta-analysis of randomised trials. Lancet 378(9793):771–784CrossRef Early Breast Cancer Trialists’ Collaborative G, Davies C, Godwin J, Gray R, Clarke M, Cutter D, Darby S, McGale P, Pan HC, Taylor C (2011) Relevance of breast cancer hormone receptors and other factors to the efficacy of adjuvant tamoxifen: patient-level meta-analysis of randomised trials. Lancet 378(9793):771–784CrossRef
34.
Zurück zum Zitat Early Breast Cancer Trialists' Collaborative G, Darby S, McGale P, Correa C, Taylor C, Arriagada R, Clarke M, Cutter D, Davies C, Ewertz M (2011) M et al: Effect of radiotherapy after breast-conserving surgery on 10-year recurrence and 15-year breast cancer death: meta-analysis of individual patient data for 10,801 women in 17 randomised trials. Lancet 378(9804):1707–1716CrossRef Early Breast Cancer Trialists' Collaborative G, Darby S, McGale P, Correa C, Taylor C, Arriagada R, Clarke M, Cutter D, Davies C, Ewertz M (2011) M et al: Effect of radiotherapy after breast-conserving surgery on 10-year recurrence and 15-year breast cancer death: meta-analysis of individual patient data for 10,801 women in 17 randomised trials. Lancet 378(9804):1707–1716CrossRef
35.
Zurück zum Zitat Ebctcg McGaleP, Taylor C, Correa C, Cutter D, Duane F, Ewertz M, Gray R, Mannu G, Peto R et al (2014) Effect of radiotherapy after mastectomy and axillary surgery on 10-year recurrence and 20-year breast cancer mortality: meta-analysis of individual patient data for 8135 women in 22 randomised trials. Lancet 383(9935):2127–2135CrossRef Ebctcg McGaleP, Taylor C, Correa C, Cutter D, Duane F, Ewertz M, Gray R, Mannu G, Peto R et al (2014) Effect of radiotherapy after mastectomy and axillary surgery on 10-year recurrence and 20-year breast cancer mortality: meta-analysis of individual patient data for 8135 women in 22 randomised trials. Lancet 383(9935):2127–2135CrossRef
36.
Zurück zum Zitat Hughes KS, Schnaper LA, Bellon JR, Cirrincione CT, Berry DA, McCormick B, Muss HB, Smith BL, Hudis CA, Winer EP et al (2013) Lumpectomy plus tamoxifen with or without irradiation in women age 70 years or older with early breast cancer: long-term follow-up of CALGB 9343. J Clin Oncol 31(19):2382–2387CrossRefPubMedPubMedCentral Hughes KS, Schnaper LA, Bellon JR, Cirrincione CT, Berry DA, McCormick B, Muss HB, Smith BL, Hudis CA, Winer EP et al (2013) Lumpectomy plus tamoxifen with or without irradiation in women age 70 years or older with early breast cancer: long-term follow-up of CALGB 9343. J Clin Oncol 31(19):2382–2387CrossRefPubMedPubMedCentral
37.
Zurück zum Zitat Cuzick J, Sestak I, Baum M, Buzdar A, Howell A, Dowsett M, Forbes JF, Investigators AL (2010) Effect of anastrozole and tamoxifen as adjuvant treatment for early-stage breast cancer: 10-year analysis of the ATAC trial. Lancet Oncol 11(12):1135–1141CrossRefPubMed Cuzick J, Sestak I, Baum M, Buzdar A, Howell A, Dowsett M, Forbes JF, Investigators AL (2010) Effect of anastrozole and tamoxifen as adjuvant treatment for early-stage breast cancer: 10-year analysis of the ATAC trial. Lancet Oncol 11(12):1135–1141CrossRefPubMed
38.
Zurück zum Zitat Wang Y, Witten I (1997) Inducing model trees for continuous classes. In: Proceedings of the ninth european conference machine learning Wang Y, Witten I (1997) Inducing model trees for continuous classes. In: Proceedings of the ninth european conference machine learning
39.
Zurück zum Zitat Gornick M (2000) Vulnerable populations and medicare services: why do disparities exist? Century Foundation Press, New York, NY Gornick M (2000) Vulnerable populations and medicare services: why do disparities exist? Century Foundation Press, New York, NY
40.
Zurück zum Zitat Du XL, Fang S, Meyer TE (2008) Impact of treatment and socioeconomic status on racial disparities in survival among older women with breast cancer. Am J Clin Oncol 31(2):125–132CrossRefPubMed Du XL, Fang S, Meyer TE (2008) Impact of treatment and socioeconomic status on racial disparities in survival among older women with breast cancer. Am J Clin Oncol 31(2):125–132CrossRefPubMed
41.
Zurück zum Zitat Nattinger AB, Pezzin LE, McGinley EL, Charlson JA, Yen TW, Neuner JM (2015) Patient costs of breast cancer endocrine therapy agents under Medicare Part D vs with generic formulations. Springerplus 4:54CrossRefPubMedPubMedCentral Nattinger AB, Pezzin LE, McGinley EL, Charlson JA, Yen TW, Neuner JM (2015) Patient costs of breast cancer endocrine therapy agents under Medicare Part D vs with generic formulations. Springerplus 4:54CrossRefPubMedPubMedCentral
42.
Zurück zum Zitat Dreyer MS, Nattinger AB, McGinley EL, Pezzin LE (2018) Socioeconomic status and breast cancer treatment. Breast Cancer Res Treat 167(1):1–8CrossRefPubMed Dreyer MS, Nattinger AB, McGinley EL, Pezzin LE (2018) Socioeconomic status and breast cancer treatment. Breast Cancer Res Treat 167(1):1–8CrossRefPubMed
Metadaten
Titel
The relationship between patient and tumor characteristics, patterns of breast cancer care, and 5-year survival among elderly women with incident breast cancer
verfasst von
Amanda L. Kong
Ann B. Nattinger
Emily McGinley
Liliana E. Pezzin
Publikationsdatum
05.06.2018
Verlag
Springer US
Erschienen in
Breast Cancer Research and Treatment / Ausgabe 2/2018
Print ISSN: 0167-6806
Elektronische ISSN: 1573-7217
DOI
https://doi.org/10.1007/s10549-018-4837-4

Weitere Artikel der Ausgabe 2/2018

Breast Cancer Research and Treatment 2/2018 Zur Ausgabe

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.